Comhábhair Ghníomhach Cógaisíochta
Progestogen agus estrogen | |||
Ainm Táirge | Sonraíocht | Ceadaithe | CAS Uimh. |
Progesterone | CP/EP/USP | CEP/EU-GMP/FDA | 57-83-0 |
MedroxyprogesteroneAicéatáit | CP/EP/USP | DMF/GMP | 71-58-9 |
Aicéatáit Megestrol | CP/EP/USP | DMF faoi Chomhdú | 595-33-5 |
Mifepristone | CP/IP | DMF/GMP | 84371-65-3 |
Aicéatáit Cyproterone | CP/PE | CEP/TGA/GMP | 427-51-0 |
Levonorgestrel | CP/EP/USP | Próiseas DMF/GMP/CEPin | 797-63-7 |
Drospirenone | EP/USP | DMF faoi Chomhdú | 67392-87-4 |
Gestóidéin | CP/PE | DMF/GMP | 60282-87-3 |
Estradiol | CP/EP/USP | DMF | 50-28-2 |
Estriol | CP/EP/USP | Faoi T&F | 50-27-1 |
Ethinyl Estradiol | CP/EP/USP | DMF/GMP | 57-63-6 |
Valerate Estradiol | CP | DMF faoi Chomhdú | 979-32-8 |
Tibolone | CP/PE | DMF | 5630-53-5 |
Dienogest | PE | DMF faoi Chomhdú | 65928-58-7 |
Fulvestrant | EP/USP | Faoi T&F | 129453-61-8 |
Androgen | |||
Ainm Táirge | Sonraíocht | Ceadaithe | CAS Uimh. |
Finasteride | CP/EP/USP | CEP/FDA/PMDA/GMP | 98319-26-7 |
Dutasteride | EP/USP | CEP/DMF | 164656-23-9 |
Aicéatáit Abiraterone | CP/USP | DMF | 154229-18-2 |
Testosterone | CP/EP/USP | DMF/CEP In-phróiseas | 58-22-0 |
Testosterone Undecanoate | CP | DMF faoi Chomhdú | 5949-44-0 |
Testosterone Cypionate | USP | DMF faoi Chomhdú | 58-20-8 |
DHEA(Prasterone) | FP/In-tí | DMF/WC/Kosher | 53-43-0 |
Hormone Cortical | |||
Ainm Táirge | Sonraíocht | Ceadaithe | CAS Uimh. |
Budesonide | CP/EP/USP | CEP/FDA/GMP | 51333-22-3 |
Desonide | USP | DMF | 638-94-8 |
Eplerenone | PE | CEP/FDA | 107724-20-9 |
Methylprednisolone | CP/EP/USP | DMF/WC | 83-43-2 |
MethylprednisoloneHemisuccinate | CP/EP/USP | DMF/WC | 2921-57-5 |
Fluticasone Propionate | CP/EP/USP | DMF | 80474- 14-2 |
Fluticasone Furoate | In-tí | Faoi T&F | 397864-44-7 |
Mometasone Furoate | CP/EP/USP | Faoi T&F | 83919-23-7 |
Daoine eile | |||
Ainm Táirge | Sonraíocht | Ceadaithe | CAS Uimh. |
Oxcarbazepine | CP/EP/USP | CEP/DMF/GMP | 28721-07-5 |
Aicéatáit Eslicarbazepine | In-tí | DMF faoi Chomhdú | 236395-14-5 |
Ganciclovir | CP/EP/USP | DMF/GMP | 82410-32-0 |
Hidreaclóiríd Valganciclovir | USP | DMF faoi Chomhdú | 175865-59-5 |
Fosfáit Oseltamivir | CP/EP/USP | DMF | 204255- 11-8 |
Esylate Nintedanib | In-tí | DMF | 656247-18-6 |
Revefenacin | In-tí | DMF i bpróiseas | 864750-70-9 |
Mireabóg | In-tí | DMF i bpróiseas | 223673-61-8 |
Hidreaclóiríd Cariprazine | In-tí | DMF i bpróiseas | 1083076-69-0 |
Lasmiditan Succinate | In-tí | DMF i bpróiseas | 439239-92-6 |
Luliconazole | In-tí | DMF i bpróiseas | 187164-19-8 |
Ainm Táirge | Sonraíocht | Ceadaithe | CAS Uimh. |
16α-Hidroxyprednisolone | Íosta 99.0% | DMF | 13951-70-7 |
16α-Aicéatáit Hiodroxyprednisolone | Íosta 98.0% | DMF | 86401-80-1 |
21-Aicéatocsa-11β-hiodrocsapregna-1,4,16-tríéin-3,20-dé-ón | Íosta 98.0% | TP | 3044-42-6 |
DHEA (Prasterone) | Íosta 99.0% | DMF/WC | 53-43-0 |
Aicéatáit DHEA (Aicéatáit Prasterone) | Íosta 99.0% | DMF | 853-23-6 |
Epiandrosterone | Íosta 99.0% | TP | 481-29-8 |
Abiraterone | Sa teach | DMF | 154229-19-3 |
Triacetyl-ganciclovir | Íosta 98.5% | TP | 86357-14-4 |
Mona-aicéitil ganciclovir | Íosta 97% | TP | 194254-40-0 |
Aicéatáit 16-Díhidropregnenolone ï ¼ 16- DPAï ¼ | Íosta 99.0% | TP | 979-02-2 |
Aicéatáit Pregnenolone | Íosta 98.0% | TP/ Kosher | 1778-02-5 |
Pregnenolone | Íosta 99.0% | TP/Cosher | 145-13-1 |
Aigéad 3-Oxo-4-androsten-17β-carbocsaileacha | Íosta 99.0% | TP | 302-97-6 |
Aigéad carbocsaileach 4-aza-5α-androstan-3-oxo-17β | Íosta 98.0% | DMF | 103335-55-3 |
Aigéad carbocsaileach 4-aza-5α-androstan-1-ene-3-oxo-17β | Íosta 98.0% | DMF | 104239-97-6 |
N-tert-búitile-3-oxo-4-aza-5α-androst-17β-carboxamide | Íosta 98.0% | DMF | 98319-24-5 |
6-clóra-1α-clóraimeitil-3,20-dé-ocsó-pregna-4,6-dien-17α-aicéatocsa | Íosta 98.0% | DMF | 17183-98-1 |
Estrone | USP36 | TP | 53-16-7 |
Flumethasone | Íosta 98.0% | TP | 2135-17-3 |